PHD2 regulates arteriogenic macrophages through TIE2 signalling.

Area of Science:

• Cardiovascular Biology
• Immunology
• Vascular Biology

Background:

• Macrophages play a role in vascular remodeling.
• Low prolyl hydroxylase domain protein 2 (PHD2) in macrophages promotes collateral vessel formation.
• The molecular mechanisms driving this pro-arteriogenic macrophage phenotype are unknown.

Purpose of the Study:

• To elucidate the molecular mechanisms by which macrophages acquire a pro-arteriogenic phenotype following arterial occlusion.
• To investigate the role of angiopoietin-1 (ANG1) and its receptor TIE2 in this process.

Main Methods:

• Femoral artery occlusion in a mouse model.
• Genetic modification of macrophages to alter PHD2 levels.
• Pharmacological blockade of ANG1.
• Gene silencing and cell depletion strategies to investigate TIE2 function.

Main Results:

• Femoral artery occlusion induces a macrophage phenotype switch via ANG1-mediated Phd2 repression.
• ANG1 blockade inhibits collateral growth by preventing Phd2 downregulation and phenotypic switch.
• ANG1-dependent Phd2 repression triggers a feed-forward loop involving TIE2 receptor induction in macrophages.
• TIE2 induction in macrophages is essential for their pro-arteriogenic functions and collateral vessel formation.

Conclusions:

• TIE2 signaling is indispensable for programming macrophages towards a pro-arteriogenic, M2-like phenotype.
• This study reveals a novel molecular pathway regulating collateral vessel formation.
• Targeting the ANG1-TIE2-PHD2 axis in macrophages offers potential therapeutic strategies for ischemic disorders.